It has been a couple of month for the reason that final earnings report for Nutrien (NTR). Shares have misplaced about 1.3% in that timeframe, outperforming the S&P 500.
Will the current detrimental development proceed main as much as its subsequent earnings launch, or is Nutrien due for a breakout? Earlier than we dive into how traders and analysts have reacted as of late, let’s take a fast have a look at its most up-to-date earnings report in an effort to get a greater deal with on the vital catalysts.
How Have Estimates Been Transferring Since Then?
It seems, estimates overview have trended downward in the course of the previous month.
The consensus estimate has shifted -11.26% because of these adjustments.
VGM Scores
At present, Nutrien has a pleasant Development Rating of B, although it’s lagging quite a bit on the Momentum Rating entrance with an F. Nonetheless, the inventory was allotted a grade of A on the worth aspect, placing it within the high 20% for this funding technique.
Total, the inventory has an mixture VGM Rating of B. Should you aren’t targeted on one technique, this rating is the one you have to be concerned about.
Outlook
Estimates have been broadly trending downward for the inventory, and the magnitude of those revisions signifies a downward shift. Notably, Nutrien has a Zacks Rank #3 (Maintain). We anticipate an in-line return from the inventory within the subsequent few months.
Solely $1 to See All Zacks’ Buys and Sells
We’re not kidding.
A number of years in the past, we shocked our members by providing them 30-day entry to all our picks for the entire sum of solely $1. No obligation to spend one other cent.
1000’s have taken benefit of this chance. 1000’s didn’t – they thought there should be a catch. Sure, we do have a cause. We wish you to get acquainted with our portfolio companies like Shock Dealer, Shares Below $10, Expertise Innovators,and extra, that closed 256 positions with double- and triple-digit features in 2024 alone.
Nutrien Ltd. (NTR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
